Description
BLOOD
First action · last action
2008-03-01 · 2008-03-01
Transactions
1
First transaction's obligation
$2,545,393
Base + all options value (sum of deltas)
$2,545,393
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2008-03-01+$2,545,393= $2,545,393
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2008-03-01 | +$2,545,393 | $2,545,393 | BLOOD |
Related awards · 10
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RFL7D3RDNTN3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0225 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $483,336 | FY2026 |
| 36C25726N0141 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,879,193 | FY2026 |
| 36C25725N0173 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $475,040 | FY2025 |
| 36C25725N0172 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $996,312 | FY2025 |
| 36C25724N0180 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $919,065 | FY2024 |
| 36C25724N0098 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $163,033 | FY2024 |
Other recipients under 6506 from 549-DALLAS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA549A11125 | MICROGENICS CORPORATION | 549-DALLAS | $22,850 | FY2011 |
| V549C10112 | BECKMAN COULTER, INC | 549-DALLAS | $1,397,953 | FY2011 |
| VA5490P3115 | IMMUCOR INC | 549-DALLAS | $4,207 | FY2010 |
| VA549A00194 | VENTANA MEDICAL SYSTEMS, INC | 549-DALLAS | $11,861 | FY2010 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA257P0158A_3600 · retrieved 2026-09-26.